The neurological disorders under schizophrenia: clinical characteristics and pathogenic aspects


Cite item

Full Text

Abstract

The review considers neurological disorders diagnosed in patients with schizophrenia. It is emphasized that these disorders can occur in patients without treatment with neuroleptics. The light neurological disorders are quite often given no proper consideration. The development of these disorders is based on phenomenon of uncoupling of frontal lobes with other sections of brain, both cortical and sub cortical ones. The description of disorders of motor functions is presented. At that, particular attention is paid to parkinsonism, dyskinesia, oculomotor disorders. The pathogenic aspects of neurological disorders in patients with schizophrenia are considered. The results of study applied to this category of patients using technique of structural and functional neurovisualization are presented. It is emphasized that further investigation of this problem will permit bettering comprehend pathogenesis of this disease with the purpose of development of more effective therapy.

About the authors

Igor’ V. Damulin

The I.M. Sechenov first Moscow state medical university

Email: damulin@mmascience.ru
doctor of medical sciences, professor of the chair of nervous diseases and neurosurgery of medical faculty The I.M. Sechenov first Moscow state medical university 119992, Moscow, Russia

Yu. L Sivolap

The I.M. Sechenov first Moscow state medical university

кафедра психиатрии и наркологии 119992, Moscow, Russia

References

  1. Lewis D.A. Is there a neuropathology of schizophrenia? Recent findings converge on altered thalamic-prefrontal cortical connectivity. Neuroscientist. 2000; 6(3): 208-18.
  2. Monji A., Kato T., Kanba S. Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci. 2009; 63(3): 257-65.
  3. Галактионова Д.Ю., Гра О.А., Низамутдинов И.И., Шершов В.Е., Кузнецова В.Е., Чудинов А.В. и др. Анализ ассоциации полиморфизма генов HTR2A, BDNF и SLC6A4 с развитием параноидной формы шизофрении и суицидального поведения. Журнал неврологии и психиатрии имени С.С. Корсакова. 2012; 112(10): 39-44.
  4. Голимбет В.Е., Коровайцева Г.И., Габаева М.В., Великая Н.В., Снегирева А.А., Каспаров С.В. и др. Изучение генов интерлейкина-1β и индоламин-2,3-диоксигеназы у больных шизофренией. Журнал неврологии и психиатрии имени С.С. Корсакова. 2014; 114(5): 46-9.
  5. Петрова Н.Н., Дорофейкова М.В. Механизмы развития нейрокогнитивного дефицита при шизофрении и современные подходы к терапии. Журнал неврологии и психиатрии имени С.С. Корсакова. 2014; 114(11): 116-23.
  6. Braskie M.N., Kohannim O., Jahanshad N., Chiang M.C., Barysheva M., Toga A.W. et al. Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults. Neuroimage. 2013; 82: 146-53.
  7. Holzman P.S. Eye movements and the search for the essence of schizophrenia. Brain Res. Rev. 2000; 31: 350-6.
  8. Raveendran V., Kumari V. Clinical, cognitive and neural correlates of self-monitoring deficits in schizophrenia: an update. Acta Neuropsychiatr. 2007; 19(1): 27-37.
  9. Takahashi S., Tanabe E., Yara K., Matsuura M., Matsushima E., Kojima T. Impairment of exploratory eye movement in schizophrenia patients and their siblings. Psychiatr. Clin. Neurosci. 2008; 62: 487-93.
  10. Whalley H.C., Whyte M.C., Johnstone E.C., Lawrie S.M. Neural correlates of enhanced genetic risk for schizophrenia. Neuroscientist. 2005; 11(3): 238-49.
  11. Moriarty J. Recognising and evaluating disordered mental states: a guide for neurologists. J. Neurol. Neurosurg. Psychiatry. 2005; 76(Suppl.1): i39-44.
  12. Lennox B.R., Lennox G.G. Mind and movement: the neuropsychiatry of movement disorders. J. Neurol. Neurosurg. Psychiatry. 2002; 72(Suppl.1): i28-31.
  13. Su J.A., Tsai C.S., Hung T.H., Chou S.Y. Change in accuracy of recognizing psychiatric disorders by non-psychiatric physicians: Fiveyear data from a psychiatric consultation-liaison service. Psychiatr. Clin. Neurosci. 2011; 65: 618-23.
  14. Walther S., Strik W. Motor symptoms and schizophrenia. Neuropsychobiology. 2012; 66(2): 77-92.
  15. Chan R.C., Chen E.Y., Cheung E.F., Cheung H.K. Executive dysfunctions in schizophrenia. Relationships to clinical manifestation. Eur. Arch. Psychiatry Clin. Neurosci. 2004; 254: 256-62.
  16. Whitty P.F., Owoeye O., Waddington J.L. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr. Bull. 2009; 35(2): 415-24.
  17. Corcoran C., Malaspina D. Traumatic brain injury as a risk factor for schizophrenia. Curr. Psychiatr. Rev. 2007; 3(1): 25-32.
  18. Holt R.I., Bushe C., Citrome L. Diabetes and schizophrenia 2005: are we any closer to understanding the link? J. Psychopharmacol. 2005; 19(Suppl. 6): 56-65.
  19. Boks M.P., Liddle P.F., Burgerhof J.G., Knegtering R., van den Bosch R.J. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr. Scand. 2004; 110: 29-35.
  20. Chen E.Y., Kwok C.L., Au J.W., Chen R.Y., Lau B.S. Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatr. Scand. 2000; 102: 342-9.
  21. Chen E.Y., Lam L.C., Chen R.Y., Nguyen D.G., Kwok C.L., Au J.W. Neurological signs and sustained attention impairment in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2001; 251: 1-5.
  22. Peralta V., Moreno-Izco L., Sanchez-Torres A., de Jalon E.G., Campos M.S., Cuesta M.J. Characterization of the defi cit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs. Schizophr. Bull. 2014; 40(1): 214-24.
  23. Sevincok L., Akoglu A., Topaloglu B., Aslantas H. Neurological soft signs in schizophrenic patients with obsessive-compulsive disorder. Psychiatr. Clin. Neurosci. 2004; 58: 274-9.
  24. Venkatasubramanian G., Latha V., Gangadhar B.N., Janakiramaiah N., Subbakrishna D.K., Jayakumar P.N. et al. Neurological soft signs in never-treated schizophrenia. Acta Psychiatr. Scand. 2003; 108: 144-6.
  25. Zhao Q., Ma Y.T., Luia S.S., Liue W.H., Xua T., Yuc X. et al. Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2013; 43: 72-8.
  26. Gay O., Plaze M., Oppenheim C., Mouchet-Mages S., Gaillard R., Olie J.P. et al. Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr. Bull. 2013; 39(4): 820-9.
  27. Focseneanu B.E., Dobrescu I., Marian G., Rusanu V. Neurological soft signs in early stage of schizophrenia associated with obsessivecompulsive disorder. J. Med. Life. 2015; 8(Special Issue): 74-81.
  28. Longworth C., Honey G., Sharma T. Functional magnetic resonance imaging in neuropsychiatry. Br. Med. J. 1999; 319: 1551-4.
  29. Morrens M., Hulstijn W., Sabbe B. Psychomotor slowing in schizophrenia. Schizophr. Bull. 2007; 33(4): 1038-53.
  30. Putzhammer A., Perfahl M., Pfeiff L., Hajak G. Gait disturbances in patients with schizophrenia and adaptation to treadmill walking. Psychiatr. Clin. Neurosci. 2005; 59: 303-10.
  31. Honer W., Kopala L.C., Rabinowitz J. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. J. Psychopharmacol. 2005; 19(3): 277-85.
  32. Payoux P., Boulanouar K., Sarramon C., Fabre N., Descombes S., Galitsky M. et al. Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study. Mov. Disord. 2003; 19(1): 83-90.
  33. McCreadie R.G., Padmavati R., Thara R., Srinivasan T.N. Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br. J. Psychiatry. 2002; 181: 135-7.
  34. Sarro S., Pomarol-Clotet E., Canales-Rodriguez E.J., Salvador R., Gomar J.J., Ortiz-Gil J. et al. Structural brain changes associa ted with tardive dyskinesia in schizophrenia. Br. J. Psychiatry. 2013; 203: 51-7.
  35. Puri B.K., Barnes T.R., Chapman M.J., Hutton S.B., Joyce E.M. Spontaneous dyskinesia in first episode schizophrenia. J. Neurol. Neurosurg. Psychiatry. 1999; 66: 76-8.
  36. Mahlberg R., Steinacher B., Mackert A., Flechtner K.M. Basic parameters of saccadic eye movements - differences between unmedicated schizophrenia and affective disorder patients. Eur. Arch. Psychiatry Clin. Neurosci. 2001; 251: 205-10.
  37. Suzuki M., Takahashi S., Matsushima E., Tsunoda M., Kurachi M., Okada C. Relationships between exploratory eye movement dysfunction and clinical symptoms in schizophrenia. Psychiatry Clin. Neurosci. 2012; 66: 187-94.
  38. Щербакова И.В., Ефанова Н.Н., Орлова В.А., Клюшник Т.П., Воскресенская Н.И., Губский Л.В. и др. Магнитно-резонансная томография лобных долей при шизофрении: корреляции с уровнем антител к фактору роста нервов в сыворотке крови. Журнал неврологии и психиатрии имени С.С. Корсакова. 2009; 109(3): 44-6.
  39. Волков В.П. Соматическая патология и причины смерти при шизофрении. Журнал неврологии и психиатрии имени С.С. Корсакова. 2009; 109(5): 14-9.
  40. Allin M., Murray R. Schizophrenia: a neurodevelopmental or neurodegenerative disorder? Curr. Opin. Psychiatry. 2002; 15: 9-15.
  41. Scorza F.A., Schmitt A., Cysneiros R.M., Arida R.M., Cavalheiro E.A., Gattaz W.F. Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia. Clinics (Sao Paulo). 2010; 65(5): 539-46.
  42. Hofer A., Weiss E.M. Advances in the neuroimaging of cognitive functions in schizophrenia. Curr. Opin. Psychiatry. 2002; 15: 3-7.
  43. Hoffman R.E., McGlashan T.H. Neural network models of schizophrenia. Neuroscientist. 2001; 7(5): 441-54.
  44. Wagner G., Koch K., Schachtzabel C., Schultz C.C., Gaser C., Reichenbach J.R. et al. Structural basis of the fronto-thalamic dysconnectivity in schizophrenia: A combined DCM-VBM study. Neuroimage Clin. 2013; 3: 95-105.
  45. Yelmo-Cruz S., Morera-Fumero A.L., Abreu-González P. S100B and schizophrenia. Psychiatry. Clin. Neurosci. 2013; 67(2): 67-75.
  46. Hill K., Mann L., Laws K.R., Stephenson C.M., Nimmo-Smith I., McKenna P.J. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr. Scand. 2004; 110(4): 243-56.
  47. Bracht T., Schnell S., Federspiel A., Razavi N., Horn H., Strik W. et al. Altered cortico-basal ganglia motor pathways refl ect reduced volitional motor activity in schizophrenia. Schizophr. Res. 2013; 143(2-3): 269-76.
  48. Greicius M. Resting-state functional connectivity in neuropsychiatric disorders. Curr. Opin. Neurol. 2008; 21: 424-30.
  49. Gorynia I., Campman V., Uebelhack R. Intermanual coordination in relation to different clinical subgroups in right-handed patients with schizophrenic and other psychotic disorders. Eur. Arch. Psychiatry Clin. Neurosci. 2003; 253: 53-9.
  50. Guo S., Kendrick K.M., Zhang J., Broome M., Yu R., Liu Z. et al. Brain-wide functional inter-hemispheric disconnection is a potential biomarker for schizophrenia and distinguishes it from depression. Neuroimage Clin. 2013; 2: 818-26.
  51. Price G., Bagary M.S., Cercignani M., Altmann D.R., Ron M.A. The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. J. Neurol. Neurosurg. Psychiatry. 2005; 76: 585-7.
  52. Middleton F.A., Strick P.L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res. Brain Res. Rev. 2000; 31(2-3): 236-50.
  53. Taylor M.A. The Fundamentals of Clinical Neuropsychiatry. New York: Oxford, Oxford University Press; 1999.
  54. Ende G., Braus D.F., Walter S., Weber-Fahr W., Henn F.A. Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2003; 253: 9-15.

Copyright (c) 2016 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies